NOMAD POWER SOLUTIONS, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable
NOMAD POWER SOLUTIONS, INC. (NMAD) had Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable of 578.06 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Option, Exercise Price Range, Beginning of Period
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions · last filed 2026-08-14
- 2026-06-30: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 578.06K shares.
- 2026-03-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 1.06M shares.
- 2025-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 1.06M shares.
- 2025-09-30: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 930.56K shares.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable |
|---|---|
| 2026-06-30 | 578.06K shares 10-Q · filed 2026-08-14 |
| 2026-03-31 | 1.06M shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 1.06M shares 10-K · filed 2026-03-31 |
| 2025-09-30 | 930.56K shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 669.73K shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 490.83K shares 10-Q · filed 2025-05-12 |
| 2024-12-31 | 409.90K shares 10-K · filed 2025-03-24 |
| 2024-09-30 | 372.81K shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 327.85K shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 283.44K shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 252.29K shares 10-K · filed 2024-03-19 |
| 2023-09-30 | 313.96K shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 301.98K shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 2.91M shares 10-Q · filed 2023-05-10 |
| 2022-12-31 | 2.82M shares 10-K · filed 2023-03-29 |
| 2022-09-30 | 2.45M shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 2.23M shares 10-Q · filed 2022-08-10 |
| 2022-03-31 | 2.10M shares 10-Q · filed 2022-05-11 |
| 2021-12-31 | 2.00M shares 10-K · filed 2022-03-21 |
| 2021-09-30 | 1.71M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 1.65M shares 10-Q · filed 2021-08-10 |
| 2021-03-31 | 1.52M shares 10-Q · filed 2021-05-12 |
| 2020-12-31 | 1.32M shares 10-K · filed 2021-03-26 |
| 2020-09-30 | 8.15M shares 10-Q · filed 2020-11-10 |
| 2020-06-30 | 7.85M shares 10-Q · filed 2020-08-10 |
| 2020-03-31 | 7.85M shares 10-Q · filed 2020-05-11 |
| 2019-12-31 | 7.85M shares 10-K · filed 2020-03-25 |
| 2019-09-30 | 8.05M shares 10-Q · filed 2019-11-08 |
| 2019-06-30 | 7.35M shares 10-Q · filed 2019-08-06 |
| 2019-03-31 | 7.55M shares 10-Q · filed 2019-05-09 |
| 2018-12-31 | 7.55M shares 10-K · filed 2019-03-25 |
| 2018-09-30 | 7.65M shares 10-Q · filed 2018-11-08 |
| 2018-06-30 | 7.47M shares 10-Q · filed 2018-08-02 |
| 2017-12-31 | 7.47M shares 10-Q · filed 2018-04-27 |
| 2017-09-30 | 6.75M shares 10-Q · filed 2017-11-09 |
| 2017-06-30 | 8.10M shares 10-Q · filed 2017-08-04 |
| 2017-03-31 | 7.97M shares 10-Q · filed 2017-05-10 |
| 2016-12-31 | 7.97M shares 10-K · filed 2017-03-29 |
| 2016-09-30 | 8.38M shares 10-Q · filed 2016-11-04 |
| 2016-06-30 | 7.38M shares 10-Q · filed 2016-08-10 |
| 2016-03-31 | 6.80M shares 10-Q · filed 2016-05-06 |
| 2015-12-31 | 6.80M shares 10-K · filed 2016-03-28 |
| 2015-09-30 | 7.10M shares 10-Q · filed 2015-11-10 |
| 2015-06-30 | 7.10M shares 10-Q · filed 2015-08-07 |
| 2015-03-31 | 6.65M shares 10-Q · filed 2015-05-13 |
| 2014-12-31 | 4.67M shares 10-K · filed 2015-03-27 |
| 2014-09-30 | 5.30M shares 10-Q · filed 2014-11-12 |
| 2014-06-30 | 5.42M shares 10-Q · filed 2014-08-08 |
| 2014-03-31 | 4.90M shares 10-Q · filed 2014-05-09 |
| 2013-12-31 | 3.00M shares 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |